Large-Joint Reconstructive Implants | Market Insights | Asia Pacific (Supplemental) | 2022
The COVID-19 pandemic has had a significant impact on the Asia Pacific large-joint reconstructive implant market given that many of these procedures are considered elective. Following the pandemic’s impact, the market will grow moderately, owing to favorable demographics, rising adoption of innovative devices, and demand for technologies that provide better patient outcomes. However, the market revenue growth will be hampered to some extent by pricing constraints, particularly in China, where a volume-based procurement initiative will expand to a wider range of orthopedic devices, including hip and knee implants.
This Medtech 360 Report provides high-level market metrics for large-joint reconstructive implants in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across an 11-year period.
